期刊文献+

乙型肝炎病毒对载脂蛋白B表达的影响及其机制探讨 被引量:7

Exploration of the effect and regulatory mechanism of hepatitis B virus on the expression of apolipoprotein B
原文传递
导出
摘要 目的 探讨乙型肝炎病毒(HBV)对载脂蛋白B(ApoB)表达的影响,并探讨其调节机制.方法 采用RT-PCR和Western blot法检测HepG2和HepG2.2.15中ApoB mRNA和蛋白的表达,全自动生化分析仪Olympus 5400检测HBV患者和健康对照者ApoB血清学水平,分析健康对照者、慢性乙型肝炎、肝纤维化和肝癌患者中ApoB表达水平的差异,将HBV感染性克隆pHBV1.3转染HepG2细胞,RT-PCR和Western blot法检测ApoB和微粒体甘油三酯转移蛋白(MTP)表达水平的变化.结果 HepG2.2.15细胞中ApoB mRNA和蛋白的表达水平较HepG2低;ApoB在慢性乙型肝炎患者和肝纤维化患者的血清学水平明显低于健康对照者(P<0.05);HBV能够在mRNA和蛋白水平抑制ApoB和MTP的表达.结论 HBV可能通过抑制MTP的表达抑制ApoB的合成和分泌. Objective To explore the effect of hepatitis B virus(HBV) on the expression of apolipoprotein B(ApoB) and its regulatory mechanism. Methods mRNA and protein expression of ApoB in HepG2 and HepG2.2.15 cells was measured by RT-PCR and Western blot, serum ApoB levels in patients with HBV infection and in healthy individuals were measured by biochemical analyzer Olympus 5400, the expression of ApoB difference among healthy individuals, patients with chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma were analyzed, HBV infectious clone pHBV1.3 was tranfected into HepG2 cells,and expression of ApoB and microsomal triglyceride transfer protein(MTP) was measured by RT-PCR and Western blot. Results Expression of ApoB mRNA and protein was lower in HepG2.2.15 cells than in HepG2 cells, serum apoB levels was much lower in patients with chronic hepatitis B and liver cirrhosis as compared to healthy individuals( P 〈0.05 ), HBV could inhibit the expression of ApoB and MTP at mRNA and protein levels. Conclusion HBV may downregulate the synthesis and secretion of ApoB via inhibits the expression of MTP.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2011年第1期30-33,共4页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金(30970143)g病毒学国家重点实验室开放基金(2010013) 中央高校基本科研业务费专项资金(302275755)
关键词 乙型肝炎病毒 载脂蛋白B 微粒体甘油三酯转移蛋白 肝纤维化 肝细胞癌 Hepatitis B virus Apolipoprotein B Microsomal triglyceride transfer protein Liver cirrhosis Hepatocellular carcinoma
  • 相关文献

参考文献7

  • 1Tsai HT, Tsai TH, Lu TM, et al. Immunopathology of hepatitis B virus infection. Int Rev Immunol, 2008, 27(6) : 427-446.
  • 2Wu KL, Zhang X, Zhang J, et al. Inhibition of hepatitis B virus gene expression by single and dual small interfering RNA treatment. Virus Res, 2005, 112(1-2): 100-107.
  • 3Zhu C, Zhang R, Liu L, et al. Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro. Clin Immunol, 2009, 131(1) : 92-97.
  • 4Norton PA, Gong Q, Mehta AS, et al. Hepatitis B virus-mediated changes of apolipoprotein mRNA abundance in cultured hepatoma cells. J Virol, 2003, 77 (9) : 5503-5506.
  • 5Cabibbo G, Craxt A. Epidemiology, risk factors and surveillance of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci, 2010, 14(4) : 352-355.
  • 6Wierzbicki AS, Hardman T, Prince WT. Future challenges for microsomal transport protein inhibitors. Curr Vasc Pharmacol, 2009, 7 (3) : 277-286.
  • 7Van der Horst DJ, Roosendaal SD, Rodenburg KW. Circulatory lipid transport: lipoprotein assembly and function from an evolutionary perspective. Mol Cell Biochem, 2009, 326 (1-2) : 105- 119.

同被引文献59

  • 1中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南[J].传染病信息,2005,18(z1):1-12. 被引量:467
  • 2黄继汉,黄晓晖,陈志扬,郑青山,孙瑞元.药理试验中动物间和动物与人体间的等效剂量换算[J].中国临床药理学与治疗学,2004,9(9):1069-1072. 被引量:1372
  • 3Emin Altiparmak,Seyfettin K(o|¨)klü,Mesut Yalinkilic,Osman Yüksel,Bahattin Cicek,Ertugrul Kayacetin,Tülin Sahin.Viral and host causes of fatty liver in chronic hepatitis B[J].World Journal of Gastroenterology,2005,11(20):3056-3059. 被引量:53
  • 4何凯茵,肖光明,张春兰.慢性乙型肝炎患者血脂和载脂蛋白水平变化及其意义[J].实用肝脏病杂志,2005,8(6):326-327. 被引量:14
  • 5Tietge UJ, Poker KH, Bahr MJ, et al. Lipid parame- ters predicting liver function in patients with cirrhosis and after liver transplantation[J]. Hepatogastroenter- ology, 1998,45 (24) : 2255-2260.
  • 6Irshad M,Dube R,Joshi YK. Impact of Viral Hepati- tis on Apo- and Lipoprotein Status in Blood[J]. Medi- cal Principles Practice, 2007,16 (4) : 310-314.
  • 7Su TC, Lee YT,Cheng TJ, et al. Chronic hepatitis B virus infection and dyslipidemia[J]. J Formos Med Assoc,2004,103(4) :286-291.
  • 8Norton PA, Gong QK, Mehta AS, et al. Hepatitis B vrus-mediated changes of Apolipoprotein mRNA a- bundance in cultured hepatoma cells[J]. Journal of vi- rology, 2003,77 (9) : 5503-5506.
  • 9Mogilenko DA, Dizhe EB, Shavva VS, et al. Role of the nuclear receptors HNF4 alpha, PPAR alpha, and LXRs in the TNF alpha-mediated inhibition of human apolipoprotein A-I gene expression in HepG2 cells [J]. Biochemistry, 2009,48 (50) .. 11950-11960.
  • 10Vergani C,Trovato G, Delia A, et al. Serum total li- pids, lipoprotein cholesterol, and apolipoprotein A in acute viral hepatitis and chronic liver disease[J]. Jour- nal of Clinical Pathology, 1978,31 (8) : 772-778.

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部